Author(s)

Maxwell Omabe, Joel C. Onyeanusi, Nworie Amos, Martin Ezeani, Simon Imakwu Okekpa

Histopathology Unitt, Department of Medical Laboratory Sciences, School of Biomedical Science, Faculty of Health Science, Ebonyi State University, Abakaliki, Nigeria.
Medical Microbiology Unit, Department of Medical Laboratory Science, Faculty of Health Science, Ebonyi State University, Abakaliki, Nigeria.
Molecular Pathology Division, Chemical Pathology and Immunology Unit, Department of Medical Laboratory Sciences, School of Biomedical Science, Faculty of Health Science, Ebonyi State University Nigeria, Ebonyi, Nigeria.

It is now generally accepted that the burden of disease due to prostate cancer has tremendously increased globally. Current data indicates that prostate cancer is the most common form of cancer in men in the United State of America, and the second leading cause of death due to cancer in men. Progression to androgen independence and subsequent therapeutic resistance and death is a common fate of patients with prostate cancer. This review highlights the gene expression profile of androgen independent prostate cancer and the possible mechanisms that results in transformation to such treatment resistant state.

Prostate Cancer; Androgen Ablation; Gene Expression; Microarrays

M. Omabe, J. C. Onyeanusi, N. Amos, M. Ezeani and S. Imakwu Okekpa, "Gene Expression Profile, Androgen Independence and Prostate Cancer," Journal of Cancer Therapy, Vol. 3 No. 5, 2012, pp. 637-644. doi: 10.4236/jct.2012.35082.